Deutsche Bank AG Buys Shares of 451,372 HCA Healthcare, Inc. $HCA

Deutsche Bank AG purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, Holdings Channel reports. The fund purchased 451,372 shares of the company’s stock, valued at approximately $175,985,000.

A number of other institutional investors have also added to or reduced their stakes in HCA. Nomura Asset Management Co. Ltd. lifted its position in HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after buying an additional 3,724 shares during the last quarter. Advisors Capital Management LLC raised its stake in shares of HCA Healthcare by 61.5% during the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after acquiring an additional 2,604 shares in the last quarter. Liberty Wealth Management LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter valued at $1,905,000. Arrowstreet Capital Limited Partnership raised its position in HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares during the period. Finally, Sunbelt Securities Inc. boosted its position in HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after buying an additional 3,945 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.8%

Shares of HCA stock opened at $412.27 on Wednesday. The stock has a fifty day moving average of $395.07 and a 200 day moving average of $445.35. The firm has a market capitalization of $89.26 billion, a price-to-earnings ratio of 13.80, a PEG ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the business earned $6.84 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities research analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.45%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent research reports. Wells Fargo & Company boosted their target price on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Leerink Partners lowered their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 7th. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Finally, Mizuho lowered their price objective on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research note on Tuesday, July 28th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $465.59.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.